Discover why Franco-Nevada Corporation is rated a sell due to weak growth, inefficiency, overvaluation, and potential gold ...

Claim denial rates and patient collection rates are both trending in the wrong direction, according to data from Kodiak Solutions.

Company Outlines Strong Momentum in Margins, Revenue, and Business Growth Entering 2025West Seneca, New York, March 27, 2025 (GLOBE NEWSWIRE) ...

UnitedHealth's 2025 guidance reflects optimism with expected revenue growth of 13% and EPS growth of 7%, aiming for a "normal ...

The market’s current conditions imply a much larger than normal risk to NVIDIA stock. Last week’s Death Cross was the ...

NLST's Q4 performance is shaped by a rich patent portfolio and notable legal victories amid a declining gross margin and ...

Nvidia stock, a winner over the past few years, has slipped in recent times. It’s important to understand short-term stock performance trends ... a $115 billion revenue run rate as customers ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly.

As is the case with many investors, the post-pandemic period really shifted my interest in growth stocks into overdrive. I ...

Savings on fuel and operational shifts (more miles and other adjustments) led income to rise in 2024 for owner-operators -- a ...

In just one year, the company's logistics arm has expanded to approximately 15,000 pin codes, supported by 6,000 logistics ...

EQS-News: Grammer Aktiengesellschaft / Key word (s): Annual Results Financial Year 2024: GRAMMER sets the course for the future 28.03.2025 / 09:00 CET/CEST The issuer is solely responsible for the ...